Cidara Therapeutics, Inc. (CDTX)
Largest Insider Buys in Sector
CDTX Stock Price History Chart
CDTX Stock Performance
About Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
Insider Activity of Cidara Therapeutics, Inc.
Over the last 12 months, insiders at Cidara Therapeutics, Inc. have bought $163,265 and sold $89,636 worth of Cidara Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Cidara Therapeutics, Inc. have bought $208,616 and sold $59,832 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Stein Jeffrey (President & CEO) — $153,565. Tari Leslie (CHIEF SCIENTIFIC OFFICER) — $9,700.
The last purchase of 8,000 shares for transaction amount of $105,680 was made by Stein Jeffrey (President & CEO) on 2024‑06‑07.
List of Insider Buy and Sell Transactions, Cidara Therapeutics, Inc.
| 2024-06-07 | Stein Jeffrey | President & CEO | 8,000 0.1804% | $13.21 | $105,680 | -1.95% | ||
| 2024-03-11 | Sale | Sandison Taylor | Chief Medical Officer | 20,662 0.0231% | $0.67 | $13,839 | -1.66% | |
| 2024-03-11 | Sale | Tari Leslie | CHIEF SCIENTIFIC OFFICER | 21,029 0.0235% | $0.67 | $14,085 | -1.66% | |
| 2024-03-11 | Sale | Shah Preetam | CFO & CBO | 18,931 0.0212% | $0.67 | $12,680 | -1.66% | |
| 2024-03-11 | Sale | Ward Shane | COO & CLO | 20,473 0.0229% | $0.67 | $13,713 | -1.66% | |
| 2023-09-11 | Sale | Sandison Taylor | Chief Medical Officer | 18,793 0.0205% | $0.95 | $17,810 | -24.64% | |
| 2023-09-11 | Sale | Tari Leslie | CHIEF SCIENTIFIC OFFICER | 18,469 0.0202% | $0.95 | $17,509 | -24.64% | |
| 2023-08-14 | Tari Leslie | CHIEF SCIENTIFIC OFFICER | 10,000 0.0118% | $0.97 | $9,700 | -19.15% | ||
| 2023-08-08 | Stein Jeffrey | President & CEO | 50,000 0.0566% | $0.96 | $47,885 | -20.59% | ||
| 2023-03-27 | Stein Jeffrey | President & CEO | 50,000 0.0653% | $1.04 | $51,855 | -9.78% | ||
| 2023-03-13 | Sale | Sandison Taylor | Chief Medical Officer | 7,203 0.0081% | $1.53 | $11,021 | -45.66% | |
| 2023-03-13 | Sale | Tari Leslie | CHIEF SCIENTIFIC OFFICER | 7,562 0.0085% | $1.53 | $11,570 | -45.66% | |
| 2023-03-13 | Sale | Shah Preetam | CFO & CBO | 6,648 0.0075% | $1.53 | $10,171 | -45.66% | |
| 2023-03-13 | Sale | Ward Shane | COO & CLO | 4,329 0.0049% | $1.53 | $6,623 | -45.66% | |
| 2023-01-12 | Sale | Tari Leslie | CHIEF SCIENTIFIC OFFICER | 11,814 0.015% | $1.20 | $14,177 | -13.33% | |
| 2022-09-19 | Sale | Shah Preetam | CFO & CBO | 15,642 0.0226% | $0.77 | $12,035 | +38.16% | |
| 2022-09-12 | Sale | Sandison Taylor | Chief Medical Officer | 18,478 0.0264% | $0.68 | $12,656 | +51.03% | |
| 2022-09-12 | Sale | Daruwala Paul | Chief Operating Officer | 16,199 0.0232% | $0.68 | $11,095 | +51.03% | |
| 2022-09-12 | Sale | Tari Leslie | CHIEF SCIENTIFIC OFFICER | 18,159 0.026% | $0.68 | $12,437 | +51.03% | |
| 2022-03-21 | Sale | Johnson Brady | Vice President, Finance | 654 0.001% | $0.81 | $530 | -12.30% |
Insider Historical Profitability
| Sandison Taylor | Chief Medical Officer | 347095 0.4022% | $11.20 | 2 | 4 | +18.64% |
| Stein Jeffrey | President & CEO | 24580 0.3667% | $11.20 | 16 | 0 | <0.0001% |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER | 258681 0.3049% | $11.20 | 1 | 6 | |
| Shah Preetam | CFO & CBO | 227210 0.1638% | $11.20 | 1 | 3 | <0.0001% |
| Ward Shane | COO & CLO | 198770 0.0935% | $11.20 | 0 | 2 | |
| BIOTECH TARGET N V | 10 percent owner | 2295272 2.5381% | $11.20 | 1 | 0 | <0.0001% |
| Daruwala Paul | Chief Operating Officer | 221099 0.2445% | $11.20 | 0 | 7 | |
| Kjellson Nina S | director | 200000 0.2212% | $11.20 | 1 | 0 | <0.0001% |
| Heron Patrick J | director | 155645 0.1721% | $11.20 | 1 | 0 | <0.0001% |
| Forrest Kevin | Chief Scientific Officer | 72354 0.08% | $11.20 | 3 | 0 | <0.0001% |
| Abdollahian Neil | Chief Business Officer | 57471 0.0636% | $11.20 | 0 | 5 | |
| Levine James E. | Chief Financial Officer | 50000 0.0553% | $11.20 | 2 | 0 | +33.09% |
| Johnson Brady | Vice President, Finance | 49366 0.0546% | $11.20 | 0 | 3 | |
| Franson Timothy R | director | 11000 0.0122% | $11.20 | 2 | 0 | <0.0001% |
| Oien Jessica | General Counsel & Secretary | 7764 0.0086% | $11.20 | 0 | 4 | |
| PEREZ ROBERT J | director | 5000 0.0055% | $11.20 | 1 | 0 | <0.0001% |
| BURGESS DANIEL D | director | 3000 0.0033% | $11.20 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Bvf Inc Il | $6.31B | 150.41 | 6.86M | 0% | +$0 | 46.34 | |
| The Vanguard Group | $3.08B | 73.36 | 3.35M | 0% | +$0 | 0.06 | |
| Renaissance Technologies | $2.35M | 56.01 | 2.55M | +41.77% | +$692,701.18 | <0.01 | |
| Alethea Capital Management LLC | $1.47B | 35.04 | 1.6M | -1.79% | -$26.84M | 92.4 | |
| Point72 Asset Management | $1.15B | 27.4 | 1.25M | 0% | +$0 | 2.19 | |
| 5Am Venture Management Llc | $1.04B | 24.87 | 1.13M | 0% | +$0 | 70.28 | |
| Geode Capital Management | $771.42M | 18.38 | 838,286 | +4.02% | +$29.83M | 0.07 | |
| BlackRock | $658.18M | 15.68 | 715,410 | -23.74% | -$204.93M | 0.02 | |
| Schonfeld Group | $507.84M | 12.1 | 552,000 | -13.06% | -$76.27M | 3.56 | |
| Gsa Capital Partners Llp | $420,000.00 | 10.01 | 456,606 | -15.51% | -$77,118.57 | 0.03 | |
| Monashee Investment Management LLC | $339.57M | 8.09 | 369,099 | 0% | +$0 | 29.29 | |
| Connor Clark & Lunn Investment Management Ltd | $291.49M | 6.95 | 316,835 | 0% | +$0 | 0.67 | |
| State Street | $249.81M | 5.95 | 271,537 | -5.4% | -$14.26M | 0.01 | |
| U.S. Bancorp | $241.11M | 5.75 | 262,072 | 0% | +$0 | 0.34 | |
| Tocqueville Asset Management | $149.96M | 3.57 | 163,000 | +71.58% | +$62.56M | 2.4 | |
| Northern Trust | $147.53M | 3.52 | 160,356 | -0.14% | -$200,559.29 | 0.03 | |
| Jeppson Wealth Management Llc | $136.76M | 3.26 | 148,650 | +4.35% | +$5.7M | 34.74 | |
| West Michigan Advisors Llc | $124.2M | 2.96 | 135,000 | New | +$124.2M | 30.25 | |
| Callan Capital | $87.56M | 2.09 | 95,169 | -8.02% | -$7.63M | 8.64 | |
| Citadel Advisors LLC | $77.77M | 1.85 | 84,536 | New | +$77.77M | 0.05 | |
| Xtx Topco Ltd | $72.69M | 1.73 | 79,012 | -50.94% | -$75.48M | 3.98 | |
| Raymond James Financial Services Advisors Inc | $71.35M | 1.7 | 77,553 | -1.67% | -$1.21M | 0.11 | |
| Two Sigma | $61.87M | 1.47 | 67,245 | New | +$61.87M | 0.11 | |
| Pale Fire Capital Se | $61.23M | 1.46 | 66,549 | 0% | +$0 | 0.33 | |
| Bridgeway Capital Management | $55.26M | 1.32 | 60,060 | 0% | +$0 | 1.03 | |
| Fny Investment Advisers Llc | $52,000.00 | 1.24 | 56,600 | New | +$52,000.00 | 0.04 | |
| Advisor Group Holdings Inc | $48.43M | 1.15 | 52,642 | 0% | +$0 | 0.11 | |
| Jane Street Capital | $42.08M | 1 | 45,736 | +232.53% | +$29.42M | 0.05 | |
| Mackenzie Financial Corp | $36.15M | 0.86 | 39,290 | +55.58% | +$12.91M | 0.05 | |
| Legacy Wealth Asset Management Llc | $27.6M | 0.66 | 30,000 | 0% | +$0 | 7.49 | |
| Charles Schwab | $24.67M | 0.59 | 26,814 | 0% | +$0 | 0.01 | |
| Two Sigma Advisers LP | $21.99M | 0.52 | 23,900 | -40.84% | -$15.18M | 0.04 | |
| Russell Investments Group Ltd | $15.73M | 0.38 | 17,100 | 0% | +$0 | 0.02 | |
| Morgan Stanley | $14.35M | 0.34 | 15,598 | -24.27% | -$4.6M | <0.01 | |
| Liberty Wealth Management Llc | $11,000.00 | 0.26 | 12,000 | 0% | +$0 | <0.01 | |
| Prudential Financial | $11.04M | 0.26 | 12,000 | 0% | +$0 | 0.02 | |
| Pure Financial Advisors, LLC | $10.58M | 0.25 | 11,500 | 0% | +$0 | 0.37 | |
| Spire Wealth Management | $9.2M | 0.22 | 10,000 | +101.17% | +$4.63M | 0.17 | |
| Mariner Llc | $9.2M | 0.22 | 10,000 | New | +$9.2M | 0.02 | |
| Tower Research Capital | $8.32M | 0.2 | 9,048 | -27.16% | -$3.1M | 0.09 | |
| Pacifica Partners Inc | $5.95M | 0.18 | 8,000 | 0% | +$0 | 2.58 | |
| UBS | $4.32M | 0.1 | 4,695 | New | +$4.32M | <0.01 | |
| Allworth Financial Lp | $736,000.00 | 0.02 | 800 | 0% | +$0 | 0.01 | |
| Wells Fargo | $592,000.00 | 0.01 | 643 | +1.58% | +$9,206.84 | <0.0001 | |
| Simplex Trading Llc | $0 | 0.01 | 525 | New | +$0 | <0.0001 | |
| JPMorgan Chase | $415,000.00 | 0.01 | 451 | -68.55% | -$904,534.37 | <0.0001 | |
| Cubist Systematic Strategies | $267,000.00 | 0.01 | 290 | +27.19% | +$57,082.76 | <0.01 | |
| Qube Research & Technologies | $48,000.00 | <0.01 | 52 | 0% | +$0 | <0.0001 |